Medications & Supplements/Prescription Drugs

Amlodipine and Benazepril Capsules Recalled for Incorrect Expiration Date

Agency Publication Date: July 28, 2025

Summary

Lupin Pharmaceuticals Inc. has recalled 7,668 bottles of Amlodipine and Benazepril HCl capsules (2.5 mg/10 mg), used to treat high blood pressure. The medication bottles were released with an incorrect expiration date of February 28, 2027, instead of the correct date of January 31, 2027. Consumers may inadvertently use the product past its tested stability period, which could affect the medication's effectiveness.

Risk

Using medication past its validated shelf life may result in the drug losing its potency or failing to meet safety standards. While the product is currently safe to use, the stability of the capsules is only guaranteed through January 2027.

What You Should Do

This recall affects Amlodipine and Benazepril HCl Capsules USP (2.5 mg/10 mg) packaged in 100-count bottles under the Lupin Pharmaceuticals brand with NDC 68180-755-01.
Check the bottle label for lot number GB01616 and the expiration date 2/28/2027. If your medication has this lot and date, it is part of the recall.
If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Lupin Pharmaceuticals Inc. for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Amlodipine and Benazepril HCl Capsules USP (2.5 mg/10 mg)

Variants: 2.5 mg/10 mg strength, 100 Capsules bottle

Lot Numbers:

GB01616 (Exp 2/28/2027)

NDC:

68180-755-01

Recall #: D-0542-2025. Released with wrong expiry date as Feb. 2027 instead of Jan. 2027.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 97182

Status: Active

Manufacturer: Lupin Pharmaceuticals Inc.

Sold By: Pharmacies nationwide

Manufactured In: India, United States

Units Affected: 7668 bottles

Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

This recall affects Amlodipine and Benazepril HCl Capsules USP (2.5 mg/10 mg) packaged in 100-count bottles under the Lupin Pharmaceuticals brand with NDC 68180-755-01.

Check the bottle label for lot number GB01616 and the expiration date 2/28/2027. If your medication has this lot and date, it is part of the recall.

If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Lupin Pharmaceuticals Inc. for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.